Issue 103 • February 2021

Online pharmacies vs. Amazon

Delivering a billion vaccine doses

Addressing the threat of AMR

Catching the next Covid-19 variant

Could real-time genomic surveillance be the key to spotting new Covid-19 variants?

In association with

02/23/2024 23:27:39
  • Home | Catching the next Covid-19 variant
  • In this issue
  • Contents
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • Mettler Toledo Company Insight
  • Data Integrity Solutions – METTLER TOLEDO
  • Comment
  • New coronavirus variant causing concern as cases spike in South Africa
  • Teva and MedinCell looking to enter LAI schizophrenia market
  • Lack of injectable anti-HIV therapies in the Japanese market
  • Prevention of thrombosis in Covid-19 patients
  • T2D therapy accepted into FDA Emerging Technology Program
  • Owen Mumford Company Insight
  • Owen Mumford
  • Butterworth
  • Molnár-Institute Company Insight
  • Molnar-Institute
  • In Depth
  • Enter Amazon Pharmacy: the beginning of a great online pharmacy fight?
  • Covid-19 vaccines have made treating racism in medicine even more urgent
  • Could Covid-19 give pharma the chance for the ultimate image makeover?
  • Delivering a billion doses with the UK VMIC
  • Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders Group
  • Saxenda: profiling the first NHS weight loss drug for a decade
  • How real-time genomic surveillance could spot new Covid-19 variants
  • A new hope for slowing disability in MS
  • Datwyler
  • Datwyler Company Insight
  • ACG Worldwide
  • Gemini Data Loggers
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
01/20/2021 00:00:00